China SXT Pharmaceuticals (SXTC) Shares Outstanding (Weighted Average) (2018 - 2025)

China SXT Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $116.0 million for Q3 2025.

• In Q3 2025, Shares Outstanding (Weighted Average) rose 3490.68% year-over-year to $116.0 million; the TTM figure through Sep 2025 stood at $116.0 million (up 3490.68% YoY), while the FY2022 annual figure was $41591.0, down 94.22% from the prior year.
• Shares Outstanding (Weighted Average) was $116.0 million for Q3 2025 at China SXT Pharmaceuticals, up from $3.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $777.5 million in Q3 2021 to a low of $41591.0 in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $214.5 million across 5 years, with a median of $102.3 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Weighted Average) jumped 5302.78% in 2021, then plunged 99.36% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $777.5 million in 2021, then plunged by 86.84% to $102.3 million in 2022, then jumped by 390.12% to $501.5 million in 2023, then slumped by 99.36% to $3.2 million in 2024, then jumped by 3490.68% to $116.0 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $116.0 million (Q3 2025), $3.2 million (Q3 2024), and $501.5 million (Q3 2023), per Business Quant data.